177 related articles for article (PubMed ID: 7805018)
61. Gene therapy for head and neck cancers.
Lamont JP; Kuhn JA; Nemunaitis JJ; McCarty TM
Oncology (Williston Park); 2001 Mar; 15(3):303-8; discussion 311-4. PubMed ID: 11301829
[TBL] [Abstract][Full Text] [Related]
62. Gene therapy for bladder cancer using adenoviral vector.
Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S
Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547
[TBL] [Abstract][Full Text] [Related]
63. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.
Xu L; Pirollo KF; Tang WH; Rait A; Chang EH
Hum Gene Ther; 1999 Dec; 10(18):2941-52. PubMed ID: 10609655
[TBL] [Abstract][Full Text] [Related]
64. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
Kasono K; Blackwell JL; Douglas JT; Dmitriev I; Strong TV; Reynolds P; Kropf DA; Carroll WR; Peters GE; Bucy RP; Curiel DT; Krasnykh V
Clin Cancer Res; 1999 Sep; 5(9):2571-9. PubMed ID: 10499635
[TBL] [Abstract][Full Text] [Related]
65. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro.
Xu L; Pirollo KF; Chang EH
Hum Gene Ther; 1997 Mar; 8(4):467-75. PubMed ID: 9054521
[TBL] [Abstract][Full Text] [Related]
66. Head and neck squamous cell carcinoma targeted chemosensitization.
Figures MR; Wobb J; Araki K; Liu T; Xu L; Zhu H; O'Malley BW; Li D
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):177-83. PubMed ID: 19643248
[TBL] [Abstract][Full Text] [Related]
67. [Gene therapy for esophageal cancer].
Shimada H; Matsubara H; Ochiai T
Nihon Geka Gakkai Zasshi; 2002 Apr; 103(4):371-5. PubMed ID: 11993227
[TBL] [Abstract][Full Text] [Related]
68. [Effect of wild-type p53 gene on the number and proteins of centrosome in leukemic K562 cells].
Wang HB; Feng WL; Huang SF; Tian WJ; Cao WX; Huang ZG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):326-31. PubMed ID: 19799129
[TBL] [Abstract][Full Text] [Related]
69. [p53 gene therapy for oral cancer].
Liu SX; Hu M
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Sep; 47(9):569-72. PubMed ID: 23141735
[No Abstract] [Full Text] [Related]
70. Gene therapy for head and neck cancer.
Frank DK
Surg Oncol Clin N Am; 2002 Jul; 11(3):589-606, vi-vii. PubMed ID: 12492081
[TBL] [Abstract][Full Text] [Related]
71. [Clinical trial of treatment of laryngeal cancer by recombinant adenovirus p53 combined with chemotherapy].
Dou X; Zhao X; Wang Y; Zeng L; Wang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 21(18):848-50. PubMed ID: 18062290
[TBL] [Abstract][Full Text] [Related]
72. Gene therapy for head and neck cancer.
Breau RL; Clayman GL
Curr Opin Oncol; 1996 May; 8(3):227-31. PubMed ID: 8804819
[TBL] [Abstract][Full Text] [Related]
73. The combination of ionizing radiation and expression of a wild type p53 gene via recombinant adenovirus induced a prominent tumour suppressing effect in human oral squamous cell carcinoma.
Wakasa T; Inoue T; Kawai N; Murakami J; Kishi K; Fukui K
Br J Radiol; 2002 Aug; 75(896):657-62. PubMed ID: 12153939
[TBL] [Abstract][Full Text] [Related]
74. Therapeutic efficiency of IL-2 gene transduced tumor vaccine for head and neck carcinoma.
Mizuno H; Yanoma S; Nishimura G; Hattori S; Ito T; Okudera K; Tsukuda M
Cancer Lett; 2000 May; 152(2):175-85. PubMed ID: 10773410
[TBL] [Abstract][Full Text] [Related]
75. [The inhibitory effect of wild-type p53 gene on the growth and proliferation of lingual squamous cell carcinoma cell line Tca8113 in nude mice].
Chen Q; Luo G; Li B
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Dec; 29(4):379-82. PubMed ID: 10743232
[TBL] [Abstract][Full Text] [Related]
76. Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy.
Chang EH; Jang YJ; Hao Z; Murphy G; Rait A; Fee WE; Sussman HH; Ryan P; Chiang Y; Pirollo KF
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):507-12. PubMed ID: 9158398
[TBL] [Abstract][Full Text] [Related]
77. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma.
Xu YH; Liu SH; Hao FR; Zhang YH
Cancer Biomark; 2018; 23(2):213-220. PubMed ID: 30198865
[TBL] [Abstract][Full Text] [Related]
78. [In search of new treatment methods for head-neck carcinoma].
Kastenbauer E; Wollenberg B
Laryngorhinootologie; 1999 Jan; 78(1):31-5. PubMed ID: 10080126
[TBL] [Abstract][Full Text] [Related]
79. Adenoviral gene therapy in head and neck cancer.
Vattemi E; Claudio PP
Drug News Perspect; 2006; 19(6):329-37. PubMed ID: 16971969
[TBL] [Abstract][Full Text] [Related]
80. [Adenovirus-mediated Rb gene transfect for head and neck cancer].
Zhang X; Liu S; Liang C; Yang H
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):194-5, 207. PubMed ID: 12600082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
